Saturday, 24 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
Company

Ascentage Pharma Reports 5.9% YOY Revenue Growth in 2023, Driven by Product Sales

October 16, 2024
Company

CanSino Biologics Reports 2023 Revenue Dip Amid Reduced COVID-19 Vaccine Demand

December 23, 2024
CompanyDeals

Recbio and Rongsheng Biotech Join Forces to Develop New Adjuvant Vaccine Technologies

October 16, 2024
Medical DeviceR&D

Tianjin University Team Develops Self-Sustaining Na-O2 Battery for Implantable Devices

October 16, 2024
CompanyDrug

Zai Lab and Novocure Report Positive Phase III Results for TTFields in NSCLC Brain Metastases

October 16, 2024
CompanyDeals

Merck Expands Global Footprint with Largest M Lab Collaboration Center in Shanghai

October 17, 2024
CompanyDeals

Kangtai Biological Partners with AstraZeneca and Beijing Daxing District to Boost Vaccine Market Presence

November 26, 2024
CompanyDrug

Jiangsu Hengrui Receives NMPA Approval for SHR-7631 ADC Clinical Study in Solid Tumors

December 3, 2024
CompanyDrug

Wuhan YZY Biopharma Initiates Phase II Study for M701 in Malignant Pleural Effusion Treatment

October 17, 2024
CompanyMedical Device

Acotec Scientific Receives NMPA Approval for Innovative Cardiovascular Devices

October 17, 2024
Company

Sanofi Launches KiDS Program in China to Boost Health Literacy in Schools

October 17, 2024
Company

WuXi Bio Reports 2023 Revenue Growth Amid COVID-19 Business Loss and Geopolitical Tensions

October 18, 2024
1 2 3 4 5 6 … 25 26
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up